![\"\"](\"https:\/\/cellfiber.jp\/en\/wp-content\/uploads\/2025\/12\/Photo_CellFiber-Extruder-591x1024.jpg\"){kind=spacer}
<\/figure>\n<\/div>\n\n\nCell therapies, such as CAR-T and iPSC-derived therapies, continue to gain global attention for their transformative therapeutic potential. Yet widespread patient access remains limited due to manufacturing complexity, long production timelines, and high cost. Scalable, cost-efficient cell culture technologies have been a significant unmet need for the industrialization of cell therapeutics.<\/p>\n\n\n\n
The CellFiber Extruder addresses these challenges by enabling GMP-compliant, large-scale cell fiber fabrication with stable, standardized, and streamlined processes. The system supports mass production by reducing overall manufacturing time while simultaneously enhancing cell function through optimized culture conditions. CellFiber will continue advancing product development and work toward establishing a full-scale, industrialized cell manufacturing platform.<\/p>\n\n\n\n
This system has been developed with support from the Japan Agency for Medical Research and Development (AMED) under the Venture Innovation and Cultivation Leading Environment (ViCLE) program since 2023, and from the New Energy and Industrial Technology Development Organization (NEDO) through the Deep Tech Startup Support Fund\/Deep Tech Startup Support Program.<\/p>\n\n\n\n
\u25a0Message from Kazuchika Furuishi, Representative Director, CEO<\/strong> \u25c6About CellFiber\u00ae Technology<\/strong> \u25c6About CellFiber Extruder<\/strong> \uff1cKey Benefits\uff1e Flexibility<\/strong> Closed System<\/strong> Traceability<\/strong> \uff1cProduct Specifications\uff1e<\/strong><\/p>\n\n\n\n
CellFiber has advanced product development with an unwavering mission: to commercialize Japan’s innovative cell culture technology globally and unlock the scalability required for the widespread adoption of cell therapy. We see a significant market opportunity ahead. As regenerative medicine and cell therapy continue their rapid expansion, the industry faces a critical bottleneck – cost-efficient, industrial-scale manufacturing of high-quality cells. This remains one of the most valuable and underserved segments in the advanced therapy value chain. We are confident that our cell fiber technology offers a truly differentiated solution by enabling high-quality, cost-effective, and scalable cell culture. These capabilities directly address the key constraints limiting commercialization of cell-based therapeutics and position of CellFiber as a strategic partner for pharmaceutical companies and CDMOs worldwide.
With the introduction of our GMP-compliant mass-production model for the CellFiber Extruder, we are entering a phase of global deployment. Our objective is to establish CellFiber as a core manufacturing technology platform in Japan and internationally, supporting the industrialization of cell therapy and creating a more efficient and accessible market.<\/p>\n\n\n\n
CellFiber\u00ae technology is an encapsulation technology that protects cells within a tubular structure made of medical-grade alginate, providing a secure, biomimetic environment for high-density cell culture. CellFiber\u00ae technology demonstrates enhanced functional maintenance, long-term viability, and greater consistency compared to conventional methods. As a result, CellFiber\u00ae is emerging as a next-generation platform for efficient, high-quality cell manufacturing.<\/p>\n\n\n\n
The CellFiber Extruder is designed for GMP-compliant cell fiber fabrication, directly encapsulating cells into culture bags. Equipped with a dedicated single-use kit and reagent set, the Extruder system offers several benefits:<\/p>\n\n\n\n
Automation<\/strong>
Streamlines cell fiber production for large-scale cultures, significantly reducing manufacturing time.<\/p>\n\n\n\n
Compatible with a wide range of applications, including suspension and adherent cell cultures, upstream and downstream processes, and multiple types of culture vessels.<\/p>\n\n\n\n
Utilizes a single-use kit to minimize contamination risks from manual handling or the surrounding work environment.<\/p>\n\n\n\n
Equipped with compliance features such as monitoring logs, access control, and audit trails to support regulatory requirements.<\/p>\n\n\n\nUser Interface<\/td> Equipped with a color LCD touchscreen featuring an intuitive graphical user interface (GUI) for easy, straightforward operation.<\/td><\/tr> Dimensions<\/td> W: 699 mm \u00d7 D: 565 mm \u00d7 H: 1380 mm (27.5\u201d \u00d7 22.2\u201d \u00d7 54.3\u201d) <\/td><\/tr> Weight<\/td> 128 kg (282.2 lb) <\/td><\/tr> Power Requirements<\/td> 95-125 VAC, 50\/60 Hz, 200VA<\/td><\/tr> Built-in PC OS<\/td> Built-in computer equipped with Windows 10<\/td><\/tr> Connectivity<\/td> 1 USB slot, 1 Ethernet port<\/td><\/tr> Regulatory Compliance<\/td> GAMP5, 21 CFR Part 11<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
\uff1cEquipment\uff1e<\/strong>
\u30fbSingle-use kit and reagent set<\/strong><\/p>\n\n\n\n